Aerin Medical
Mountain View, CA · Founded 2011 · CIK 0001536647 · Medtech · Private
Minimally invasive medical devices for nasal airway treatment using radiofrequency energy
aerinmedical.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $141M
- 9 Form D · Dec 2024
- 21 months since last filing
- Contracts
- $44K
- 2 awards · Veterans Affairs
- #579 of 4531 in medtech
- Patents
- 40
- 27 granted · 13 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20112013201520172019202120232025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $125,000 | |
| Private capital raised | Form D · SEC | $125,000 | |
| Private capital raised | Form D · SEC | $524,998 | |
| Private capital raised | Form D · SEC | $2,327,326 | |
| Private capital raised | Form D · SEC | $10,572,276 | |
| Private capital raised | Form D · SEC | $10,000,000 | |
| Private capital raised | Form D · SEC | $49,749,882 | |
| Federal contract | Department of Veterans Affairs · Arc Stylus | $21,450 | |
| Private capital raised | Form D · SEC | $34,880,478 | |
| Federal contract | Department of Veterans Affairs · Radiofrequency Devices | $23,002 | |
| Private capital raised | Form D · SEC | $32,477,189 |
Federal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 576 | BACTERIOSCAN, INC. | $48K | $3.8M |
| 577 | Truvian Sciences | $48K | — |
| 578 | Fusion Orthopedics, LLC | $45K | $1.2M |
| 579 | Aerin Medical | $44K | $141M |
| 580 | Align Technology | $44K | $72M |
| 581 | Tandem Diabetes Care | $42K | $70M |
| 582 | Ivantis, Inc. | $40K | $69M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Kern BhugraDirector
- Matthew BrokawDirector · Executive Officer
- Andre ChengExecutive Officer
- Fred DingerDirector · Executive Officer
- Ryan DrantDirector
- William FacteauDirector
- Greg GarfieldDirector
- Gregory GarfieldDirector
- Nael KassarDirector
- Karen LongDirector
- Bill McClellanExecutive Officer
- Kevin ReillyDirector
- Irina RidleyExecutive Officer
- Matthew SalkeldExecutive Officer
- Peter SavasDirector
- Valeska SchroederDirector
- Derrick SungExecutive Officer
- David ThrowerDirector
- John WhiteDirector
- Scott WolfDirector · Executive Officer
- Scott Wolf, MDDirector · Executive Officer · Promoter
- Greg YoungDirector
- Gregory YoungDirector
Patents
- Nasal Neuromodulation Devices And Methodsapplication
- Methods For Reducing Mucus Productionapplication
- Methods And Devices To Treat Nasal Airwaysgranted
- Soft Palate Treatmentgranted
- Methods And Devices To Treat Nasal Airwaysgranted
- Soft Palate Treatmentapplication
- Methods For Reducing Mucus Productiongranted
- Methods And Devices To Treat Nasal Airwaysapplication
- Eustachian Tube Modificationgranted
- Nasal Airway Tissue Treatment System And Methodapplication
- Methods And Devices To Treat Nasal Airwaysgranted
- Methods For Reducing Mucus Productiongranted
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.